Bromodeoxyuridine (BrDU) antibody

Details for Product No. ABIN153035
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

(157), (13), (6), (6), (5), (2), (1)
(128), (34), (30), (15), (1)
(27), (12), (8), (4), (3), (3), (3), (3), (3), (3), (3), (3), (1), (1), (1)
Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunofluorescence (IF), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB), ELISA
(109), (91), (46), (46), (40), (35), (35), (30), (20), (12), (3), (3), (1)
Pubmed 3 references available
Catalog no. ABIN153035
Quantity 0.25 mg
Contact our Customer Service for availability and price in your country.
Shipping to United States (Change)
Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Bromodeoxyuridine coupled to keyhole limpet hemocyanin (KLH).
Specificity Species Reactivity: All.
Cross-Reactivity Human
Purification Purified
Background To measure DNA synthesis or cell proliferation, 5-bromo2’-deoxy-uridine (BrdU) can beincorporated into DNA in place of thymindine. Cells, which have incorporated BrdU intoDNA, can be quickly detected using a monoclonal antibody against BrdU. The binding ofthe antibody is achieved by denaturation of the DNA. This is usually obtained byexposing the cells to acid, or heat. Alternate Names: anti-Bromodeoxyuridine antibody, anti-BUdr antibody.
Research Area Proliferation Markers
Application Notes Fixation in cold methanol for 30 minutes followed by immersion in 7x10-3 M NaOH for10-15 seconds allows BrdU staining with the simultaneous detection of nuclearcytoplasmic and membrane assigns as well as preservation of morphological detail.The unconjugated antibody was tested using immunoprecipitation against 5-MethylCytosine (5-MeC) and bromodeoxyuridine (BrdU) or control (no antigen) and assayedby A-405 spectrophotometry. At a concentration of 25 ug/mL, this product demonstrates8 fold higher reactivity against BrdU than 5-MeC. Product titers out to 50 ng/mL in thepurified form.For best results on unconjugated antibody, use the product at a concentration of 25 to100 ug/mL. Nearly complete immunoprecipitation was obtained at concentrations of 100to 500ug/mL. The product has also been tested for utility for staining ofbromodeoxyuridine incorporated into DNA of replicating cells. When utilized at a purifiedconcentration of 10 ug/mL, the product is comparable to commercially availablemonoclonal antibodies commonly used for the same purpose.A key issue is that it is necessary to denature the DNA so as to expose the base to theantibodies. One protocol is: Sachiko Matsu uraa and Kazuo SuzukiaImmunohistochemical Analysis of DNA Synthesis During Chronic Stimulation withIsoproterenol in Mouse Submandibular Gland . Journal of Histochemistry andCytochemistry, Vol. 45, 1137-1146, Immunohistochemistry DNA-synthesizing cells weredetected by peroxidase-anti-peroxidase (PAP) immunostaining with anti-BrdUantibodies by the method of Harms et al. 1986 , which was slightly modified as follows:Sections were treated with 2 N HCl at 60C for 15 min and washed in running water for15 min. After dehydration in an ethanol series, the sections were etched with xylene (15min, twice). Nuclear proteins, which mask incorporated BrdU, were digested with0.025% protease (Type V, Sigma) in PBS at 37C for 10 min, and the sections were thenwashed with cold PBS three times for 5 min.
Restrictions For Research Use only
Concentration 1.93 mg/ml
Buffer 0.15M PBS. pH 7.5. Preservative: No preservatives.
Preservative Without preservative
Storage -20 °C
Supplier Images
anti-Bromodeoxyuridine (BrDU) antibody anti-Bromodeoxyuridine (BrDU) antibody
General Campana, Coustan-Smith, Janossy: "Double and triple staining methods for studying the proliferative activity of human B and T lymphoid cells." in: Journal of immunological methods, Vol. 107, Issue 1, pp. 79-88, 1988 (PubMed).

Morris, Solomon: "BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair." in: Human molecular genetics, Vol. 13, Issue 8, pp. 807-17, 2004 (PubMed).

Cooper, Isacson: "Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 24, Issue 41, pp. 8924-31, 2004 (PubMed).

Hosts (128), (34), (30), (15), (1)
Reactivities (157), (13), (6), (6), (5), (2), (1)
Applications (109), (91), (46), (46), (40), (35), (35), (30), (20), (12), (3), (3), (1)
Conjugates (27), (12), (8), (4), (3), (3), (3), (3), (3), (3), (3), (3), (1), (1), (1)
back to top